Z Mike Chirenje, Nicholas Dhibi, H Hunter Handsfield1, Elizabeth Gonese2, Beth Tippett Barr2, Lovemore Gwanzura, Ahmed S Latif3, Dumisili Venessa Maseko4, Ranmini S Kularatne4, Mufuta Tshimanga5, Peter H Kilmarx, Anna Machiha6, Owen Mugurungi6, Cornelis A Rietmeijer. 1. Division of Allergy and Infectious Diseases, Department of Medicine and the Center for AIDS and STD, University of Washington School of Medicine, Seattle WA. 2. Division of Global Health and Tuberculosis, Centers for Disease Control and Prevention. 3. Public Health Specialist, Brisbane, Australia. 4. Sexually Transmitted Infections Section, Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa. 5. Surveillance, Evaluation, Assessment and Monitoring (SEAM) Project, Department of Community Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe. 6. Zimbabwe Ministry of Health and Child Care, Harare, Zimbabwe.
Abstract
INTRODUCTION: Symptomatic vaginal discharge is a common gynecological condition managed syndromically in most developing countries. In Zimbabwe, women presenting with symptomatic vaginal discharge are treated with empirical regimens that commonly cover both sexually transmitted infections (STIs) and reproductive tract infections, typically including a combination of an intramuscular injection of kanamycin, and oral doxycycline and metronidazole regimens. This study was conducted to determine the current etiology of symptomatic vaginal discharge and assess adequacy of current syndromic management guidelines. METHODS: We enrolled 200 women with symptomatic vaginal discharge presenting at 6 STI clinics in Zimbabwe. Microscopy was used to detect bacterial vaginosis and yeast infection. Nucleic acid amplifications tests were used to detect Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, and Mycoplasma genitalium. In addition, serologic testing was performed to detect human immunodeficiency virus (HIV) infection. RESULTS: Of the 200 women, 146 (73%) had an etiology detected, including bacterial vaginosis (24.7%); N. gonorrhoeae (24.0%); yeast infection (20.7%); T. vaginalis (19.0%); C. trachomatis (14.0%) and M. genitalium (7.0%). Among women with STIs (N = 90), 62 (68.9%) had a single infection, 18 (20.0%) had a dual infection, and 10 (11.1%) had 3 infections.Of 158 women who consented to HIV testing, 64 (40.5%) were HIV infected.The syndromic management regimen covered 115 (57.5%) of the women in the sample who had gonorrhea, chlamydia, M. genitalium, or bacterial vaginosis, whereas 85 (42.5%) of women were treated without such diagnosis. CONCLUSIONS: Among women presenting with symptomatic vaginal discharge, bacterial vaginosis was the most common etiology, and gonorrhea was the most frequently detected STI. The current syndromic management algorithm is suboptimal for coverage of women presenting with symptomatic vaginal discharge; addition of point of care testing could compliment the effectiveness of the syndromic approach.
INTRODUCTION: Symptomatic vaginal discharge is a common gynecological condition managed syndromically in most developing countries. In Zimbabwe, women presenting with symptomatic vaginal discharge are treated with empirical regimens that commonly cover both sexually transmitted infections (STIs) and reproductive tract infections, typically including a combination of an intramuscular injection of kanamycin, and oral doxycycline and metronidazole regimens. This study was conducted to determine the current etiology of symptomatic vaginal discharge and assess adequacy of current syndromic management guidelines. METHODS: We enrolled 200 women with symptomatic vaginal discharge presenting at 6 STI clinics in Zimbabwe. Microscopy was used to detect bacterial vaginosis and yeastinfection. Nucleic acid amplifications tests were used to detect Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, and Mycoplasma genitalium. In addition, serologic testing was performed to detect human immunodeficiency virus (HIV) infection. RESULTS: Of the 200 women, 146 (73%) had an etiology detected, including bacterial vaginosis (24.7%); N. gonorrhoeae (24.0%); yeastinfection (20.7%); T. vaginalis (19.0%); C. trachomatis (14.0%) and M. genitalium (7.0%). Among women with STIs (N = 90), 62 (68.9%) had a single infection, 18 (20.0%) had a dual infection, and 10 (11.1%) had 3 infections.Of 158 women who consented to HIV testing, 64 (40.5%) were HIV infected.The syndromic management regimen covered 115 (57.5%) of the women in the sample who had gonorrhea, chlamydia, M. genitalium, or bacterial vaginosis, whereas 85 (42.5%) of women were treated without such diagnosis. CONCLUSIONS: Among women presenting with symptomatic vaginal discharge, bacterial vaginosis was the most common etiology, and gonorrhea was the most frequently detected STI. The current syndromic management algorithm is suboptimal for coverage of women presenting with symptomatic vaginal discharge; addition of point of care testing could compliment the effectiveness of the syndromic approach.
Authors: Sakhile Mhlongo; Precious Magooa; Etienne E Müller; Noel Nel; Frans Radebe; Elizabeth Wasserman; David A Lewis Journal: Sex Transm Dis Date: 2010-09 Impact factor: 2.830
Authors: Koleka Mlisana; Nivashnee Naicker; Lise Werner; Lindi Roberts; Francois van Loggerenberg; Cheryl Baxter; Jo-Ann S Passmore; Anneke C Grobler; A Willem Sturm; Carolyn Williamson; Katharina Ronacher; Gerhard Walzl; Salim S Abdool Karim Journal: J Infect Dis Date: 2012-04-19 Impact factor: 5.226
Authors: Nazmul Alam; Eric Chamot; Sten H Vermund; Kim Streatfield; Sibylle Kristensen Journal: BMC Public Health Date: 2010-01-18 Impact factor: 3.295
Authors: Cornelis A Rietmeijer; More Mungati; Peter H Kilmarx; Beth Tippett Barr; Elizabeth Gonese; Ranmini S Kularatne; David A Lewis; Jeffrey D Klausner; Luanne Rodgers; H Hunter Handsfield Journal: Sex Transm Dis Date: 2019-09 Impact factor: 2.830
Authors: Mahlape P Mahlangu; Etienne E Müller; Johanna M E Venter; Dumisile V Maseko; Ranmini S Kularatne Journal: Sex Transm Dis Date: 2019-06 Impact factor: 2.830
Authors: Cara M Dunaiski; Marleen M Kock; Hyunsul Jung; Remco P H Peters Journal: Antimicrob Resist Infect Control Date: 2022-08-15 Impact factor: 6.454
Authors: Kevin Martin; Ioana D Olaru; Nyasha Buwu; Tsitsi Bandason; Michael Marks; Ethel Dauya; Joice Muzangwa; David Mabey; Chido Dziva Chikwari; Suzanna C Francis; Mandikudza Tembo; Constancia Mavodza; Victoria Simms; Constance R S Mackworth-Young; Anna Machiha; Katharina Kranzer; Rashida A Ferrand Journal: Lancet Child Adolesc Health Date: 2021-01-06